Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)
China flag China · Delayed Price · Currency is CNY
6.80
+0.16 (2.41%)
Feb 4, 2026, 3:00 PM CST

SHA:605199 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-168.12-274.4610.8585.6872.14121.5
Depreciation & Amortization
76.6776.6758.8851.0348.1743.51
Other Amortization
2.782.780.830.540.310.3
Loss (Gain) From Sale of Assets
-0.04-0.040.080.010.090.2
Asset Writedown & Restructuring Costs
0.860.86-0.541.8310.92
Loss (Gain) From Sale of Investments
-8.18-8.18-0.35-0.55-0.32-1.72
Provision & Write-off of Bad Debts
4.094.0915.58-0.233.23-
Other Operating Activities
201.4944.4333.3522.8912.6511.41
Change in Accounts Receivable
17.817.8-63.98-245.05-34.15-197.45
Change in Inventory
-173.06-173.06-74.9-6.06-28.79-35.84
Change in Accounts Payable
165.42165.4248.19326.920.3864.07
Operating Cash Flow
114.28-149.1228.25238.71102.483.3
Operating Cash Flow Growth
45.94%--88.17%132.93%3005.68%-97.72%
Capital Expenditures
-85.02-156.23-489.2-392.32-137.62-59.42
Sale of Property, Plant & Equipment
0.070.070.080.260.110.08
Cash Acquisitions
---35.1---
Divestitures
-13.68----
Investment in Securities
----19.540.111.72
Other Investing Activities
------20
Investing Cash Flow
-84.95-142.48-524.21-411.6-117.1-77.62
Long-Term Debt Issued
-735.741,140686.02464.22242.27
Long-Term Debt Repaid
--620.52-552.39-507.52-260.53-123.74
Net Debt Issued (Repaid)
-88.27115.22588.08178.5203.68118.53
Issuance of Common Stock
-----173.12
Common Dividends Paid
-38.54-92.16-31.56-14.35-73.75-8
Other Financing Activities
55.43-1.23-3.47-16.38-22.55
Financing Cash Flow
-71.3821.83553.06164.15146.32261.1
Net Cash Flow
-42.04-269.7757.1-8.74131.7186.79
Free Cash Flow
29.26-305.35-460.95-153.61-35.14-56.12
Free Cash Flow Margin
2.75%-21.60%-25.68%-10.14%-2.60%-4.83%
Free Cash Flow Per Share
0.08-0.77-1.27-0.38-0.09-0.15
Cash Income Tax Paid
116.48147.75133.28138.47124.58149.62
Levered Free Cash Flow
200.72-208.27-516.59-206.31-52.48-129.2
Unlevered Free Cash Flow
227.45-188.43-505.19-195.06-43.81-123.51
Change in Working Capital
4.734.73-90.9878.81-35.62-182.82
Source: S&P Global Market Intelligence. Standard template. Financial Sources.